Shares of Apple, Inc. (NASDAQ:AAPL) were slightly lower in premarket trading on Thursday. The company's Q3 results and management commentary are expected to influence the stock and broader market. Apple's performance is considered a litmus test for consumer health due to its consumer-focused products. The stock has significant weightings in the S&P 500 Index and the Nasdaq Composite Index. Analysts expect an in-line to slightly better June quarter, based on brisk iPhone upgrade activity, especially in China. JPMorgan's Samik Chatterjee established a 2024 price target of $220 for the stock.